{"id":1067954,"date":"2020-11-20T14:20:55","date_gmt":"2020-11-20T19:20:55","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/auris-medical-launches-website-for-am-301-focused-subsidiary-altamira-medica\/"},"modified":"2024-08-18T11:41:20","modified_gmt":"2024-08-18T15:41:20","slug":"auris-medical-launches-website-for-am-301-focused-subsidiary-altamira-medica","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/auris-medical-launches-website-for-am-301-focused-subsidiary-altamira-medica.php","title":{"rendered":"Auris Medical Launches Website for AM-301-focused Subsidiary, Altamira Medica"},"content":{"rendered":"<p><![CDATA[Hamilton, Bermuda, November 20, 2020 \u2013 Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology, rhinology and allergy and CNS disorders, today announced the launch of a dedicated website for its affiliate Altamira Medica Ltd. The website, www.altamiramedica.com, offers quick and easy access to information about the Company\u2019s development of AM-301, a drug-free nasal spray intended for self-protection against risks from exposure to airborne viruses and allergens.]]><\/p>\n<p>More here:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener noreferrer\" href=\"http:\/\/www.globenewswire.com\/news-release\/2020\/11\/20\/2131013\/0\/en\/Auris-Medical-Launches-Website-for-AM-301-focused-Subsidiary-Altamira-Medica.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"Auris Medical Launches Website for AM-301-focused Subsidiary, Altamira Medica\">Auris Medical Launches Website for AM-301-focused Subsidiary, Altamira Medica<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>More here: Auris Medical Launches Website for AM-301-focused Subsidiary, Altamira Medica <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/auris-medical-launches-website-for-am-301-focused-subsidiary-altamira-medica.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-1067954","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1067954"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1067954"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1067954\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1067954"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1067954"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1067954"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}